Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 90 99m 4?
Displaying drugs 8426 - 8450 of 10339 in total
Investigational
Matched Iupac: … lambda4-cerium(4+) dioxidandiide …
HQP1351 is under investigation in clinical trial NCT03883100 (A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation).
Investigational
Matched Iupac: … 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{1H-pyrazolo[3,4-b]pyridin …
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
Matched Iupac: … N-(4-ethoxyphenyl)acetamide …
Experimental
Matched Iupac: … [4-(carbamimidoylsulfanyl)butyl]dimethylamine …
Vanillyl alcohol has been used in trials studying the treatment of Smoking.
Investigational
Matched Iupac: … 4-(hydroxymethyl)-2-methoxyphenol …
Aminomethylbenzoic acid may be useful as an antifibrinolytic agent .
Experimental
Matched Iupac: … 4-(aminomethyl)benzoic acid …
Experimental
Matched Iupac: … diethyl 4-nitrophenyl phosphate …
Experimental
Matched Iupac: … 4-chlorobenzene-1,3-disulfonamide …
Experimental
Matched Iupac: … N-(4-aminobenzenesulfonyl)guanidine …
Experimental
Vet approved
Matched Iupac: … 4-(dimethylamino)-2,2-diphenylpentanamide …
Experimental
Matched Iupac: … {6-[4-(4-bromobenzoyl)-3-fluorophenoxy]hexyl}(methyl)(prop-2-en-1-yl)amine …
Investigational
Matched Iupac: … 4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxypiperidin-4-yl]benzamide …
QGC001 has been used in trials studying the treatment of Essential Hypertension.
Investigational
Matched Iupac: … (3S)-3-amino-4-{[(2S)-2-amino-4-sulfobutyl]disulfanyl}butane-1-sulfonic acid …
Experimental
Matched Iupac: … N-(4-chlorophenyl)-2-phenyl-N-[1-(propan-2-yl)piperidin-4-yl]acetamide …
Orelabrutinib is under investigation in clinical trial NCT04305197 (A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)).
Investigational
Matched Iupac: … 2-(4-phenoxyphenyl)-6-[1-(prop-2-enoyl)piperidin-4-yl]pyridine-3-carboxamide …
Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Iupac: … ]-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]pyrrolidine-2-carboxamide ... (2S,4R)-1-[(2S)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl]-N-[(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl …
GLPG0187 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Iupac: … (2S)-3-({2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl}amino ... )-2-(4-methoxybenzenesulfonamido)propanoic acid …
Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).
Investigational
Matched Iupac: … (R)-imino(methyl)(1-{6-[(3R)-3-methylmorpholin-4-yl]-2-{1H-pyrrolo[2,3-c]pyridin-4-yl}pyrimidin-4-yl} …
PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro), which is used by viruses like SARS-CoV-2 to assemble and multiply . Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its anti-viral effects . PF-07304814, developed by Pfizer, was first identified during the...
Investigational
Matched Iupac: … [(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin …
Matched Description: … PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro)
Experimental
Matched Iupac: … 4-oxopentanoic acid …
Experimental
Matched Iupac: … (4-bromophenyl)methanol …
Experimental
Illicit
Matched Iupac: … 1-methyl-4-phenyl-3-(prop-2-en-1-yl)piperidin-4-yl propanoate …
Experimental
Matched Iupac: … (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide …
Displaying drugs 8426 - 8450 of 10339 in total